Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2573767 | Trends in Pharmacological Sciences | 2006 | 6 Pages |
Abstract
Schizophrenia is a grave psychiatric disorder with psychotic symptoms and an enigmatic etiology. Family studies have strongly indicated that genetic risk factors have a role in this disease. Recent findings, together with previously established evidence, highlight the PDZ-domain-containing protein interacting with C-kinase 1 (PICK1) as a promising candidate for a schizophrenia susceptibility gene. Here, we outline possible molecular mechanisms, discuss clinical case-studies that indicate an unexpected role of PICK1 in schizophrenia and discuss potential avenues for pharmacological manipulation of PICK1.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Kumlesh K. Dev, Jeremy M. Henley,